1 – 3 of 3
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors : a multicenter IMWG study
(
- Contribution to journal › Article
- 2016
-
Mark
Management of relapsed multiple myeloma: Recommendations of the international myeloma working group.
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma.
(
- Contribution to journal › Scientific review